Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-08
2005-03-08
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S277000, C546S152000, C546S339000
Reexamination Certificate
active
06864264
ABSTRACT:
The present invention relates to the compounds of the general formula (I), a composition for and a method of treating breast cancer or other proliferative disorders in a subject using a compound of general formula [I],wherein the substituents are as defined in the specification.
REFERENCES:
patent: 6348625 (2002-02-01), Anderson
patent: 20020010337 (2002-01-01), Bernardon
patent: 20020022665 (2002-02-01), Rosen
patent: 20020040029 (2002-04-01), Bowen
patent: 20020143064 (2002-10-01), Chiron
patent: WO 9323375 (1993-11-01), None
Kaimari, Tawfeq Abdul-Raheem, “The Design, Synthesis, Characterization and Biological Screening Evaluation of 1-Adamantyl Chalcones As Potential Breast Cancer Agents,” Dissertation submitted to Clark Atlanta University, Department of Chemistry, Atlanta, GA Dec. 1999 (published Aug. 20, 2001, certificate enclosed) (Abstract only).
Anderson Gloria L.
Kaimari Tawfeq Abdul-Raheem
Davis Zinna Northington
Troutman Sanders LLP
LandOfFree
1-adamantyl chalcones for the treatment of proliferative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-adamantyl chalcones for the treatment of proliferative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-adamantyl chalcones for the treatment of proliferative... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3445932